GAP control: Regulating the regulators of small GTPases

Trends in Cell Biology

Volumn 14, Issue 7, 2004, Pages 377-385

  Bernards, Andre ^a   Settleman, Jeffrey ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHOLIPID; REGULATOR PROTEIN;

ENZYME ACTIVITY; GENE MUTATION; GENETIC CODE; HUMAN; LOWE SYNDROME; MICROPHTHALMIA; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FAMILY; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; STIMULATION; TUBEROUS SCLEROSIS;

GTP PHOSPHOHYDROLASES; GTPASE-ACTIVATING PROTEINS; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 3042796979     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2004.05.003     Document Type: Review

References (62)

1. Takai Y., et al. Small GTP-binding proteins. Physiol. Rev. 81:2001;153-208
2. Symons M., Settleman J. Rho family GTPases: more than simple switches. Trends Cell Biol. 10:2000;415-419
3. McCormick F. ras GTPase activating protein: signal transmitter and signal terminator. Cell. 56:1989;5-8
4. Vincent S., Settleman J. Inhibition of RhoGAP activity is sufficient for the induction of Rho-mediated actin reorganization. Eur. J. Cell Biol. 78:1999;539-548
5. Bernards A. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim. Biophys. Acta. 1603:2003;47-82
6. Hu F., Elledge S.J. Bub2 is a cell cycle regulated phospho-protein controlled by multiple checkpoints. Cell Cycle. 1:2002;351-355
7. Hu F., et al. Regulation of the Bub2/Bfa1 GAP complex by Cdc5 and cell cycle checkpoints. Cell. 107:2001;655-665
8. Geymonat M., et al. In vitro regulation of budding yeast Bfa1/Bub2 GAP activity by Cdc5. J. Biol. Chem. 278:2003;14591-14594
9. Hofken T., Schiebel E. Novel regulation of mitotic exit by the Cdc42 effectors Gic1 and Gic2. J. Cell Biol. 164:2004;219-231
10. Li Y., et al. TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem. Sci. 29:2004;32-38
11. Nellist M., et al. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Hum. Mol. Genet. 10:2001;2889-2898
12. Inoki K., et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:2002;648-657
13. Mochizuki N., et al. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with Gαi. Nature. 400:1999;891-894
14. z and Rap1GAP suggests a novel form of cellular cross-talk. J. Biol. Chem. 274:1999;36663-36669
15. o with Rap1 GTPase-activating protein. J. Biol. Chem. 274:1999;21507-21510
16. Ban R., et al. Human mitotic spindle-associated protein PRC1 inhibits MgcRacGAP activity toward Cdc42 during the metaphase. J. Biol. Chem. 279:2004;16394-16402
17. Jenna S., et al. The activity of the GTPase-activating protein CdGAP is regulated by the endocytic protein intersectin. J. Biol. Chem. 277:2002;6366-6373
18. Wennerberg K., et al. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr. Biol. 13:2003;1106-1115
19. Lambert J.M., et al. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat. Cell Biol. 4:2002;621-625
20. Drugan J.K., et al. The Ras/p120 GTPase-activating protein (GAP) interaction is regulated by the p120 GAP pleckstrin homology domain. J. Biol. Chem. 275:2000;35021-35027
21. Fauchereau F., et al. The RhoGAP activity of OPHN1, a new F-actin-binding protein, is negatively controlled by its amino-terminal domain. Mol. Cell. Neurosci. 23:2003;574-586
22. Feng L., et al. PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin. FEBS Lett. 557:2004;275-282
23. Okabe T., et al. RICS, a novel GTPase-activating protein for Cdc42 and Rac1, is involved in the β-catenin-N-cadherin and N-methyl-D-aspartate receptor signaling. J. Biol. Chem. 278:2003;9920-9927
24. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 279:2004;17980-17988
25. Sano H., et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278:2003;14599-14602
26. Minoshima Y., et al. Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during cytokinesis. Dev. Cell. 4:2003;549-560
27. Yu S., Roth M.G. Casein kinase I regulates membrane binding by ARF GAP1. Mol. Biol. Cell. 13:2002;2559-2570
28. Sordella R., et al. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell. 113:2003;147-158
29. Tsai M.H., et al. The effect of GTPase activating protein upon ras is inhibited by mitogenically responsive lipids. Science. 243:1989;522-526
30. Bollag G., McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature. 351:1991;576-579
31. Serth J., et al. The inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids is due to physical association of the C-terminal domain of the GTPase activating protein with micellar structures. EMBO J. 10:1991;1325-1330
32. IP4BP PH domain directing plasma membrane targeting. Curr. Biol. 7:1997;1007-1010
33. Cozier G.E., et al. Engineering the phosphoinositide-binding profile of a class I pleckstrin homology domain. J. Biol. Chem. 278:2003;39489-39496
34. 2+-dependent inactivation of the Ras-MAPK pathway. Curr. Biol. 11:2001;981-986
35. α1-Chimaerin and effect of lipids. Methods Enzymol. 256:1995;114-125
36. Santy L.C., et al. Regulation of ARNO nucleotide exchange by a PH domain electrostatic switch. Curr. Biol. 9:1999;1173-1176
37. Kruljac-Letunic A., et al. The tyrosine kinase Pyk2 regulates Arf1 activity by phosphorylation and inhibition of the Arf-GTPase-activating protein ASAP1. J. Biol. Chem. 278:2003;29560-29570
38. Ligeti E., et al. Phospholipids can switch the GTPase substrate preference of a GTPase-activating protein. J. Biol. Chem. 279:2004;5055-5058
39. Peter B.J., et al. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science. 303:2004;495-499
40. Bigay J., et al. Lipid packing sensed by ArfGAP1 couples COPI coat disassembly to membrane bilayer curvature. Nature. 426:2003;563-566
41. r protein n-chimaerin, related to both the regulatory domain of protein kinase C and BCR, the product of the breakpoint cluster region gene. J. Mol. Biol. 211:1990;11-16
42. Hattori M., et al. Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol. Cell. Biol. 15:1995;552-560
43. Cichowski K., et al. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes Dev. 17:2003;449-454
44. Yang J.Y., Widmann C. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol. Cell. Biol. 21:2001;5346-5358
45. Huber M., et al. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J. Virol. 73:1999;3587-3594
46. Smith C.C., et al. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth. J. Virol. 74:2000;10417-10429
47. RhoGAP is cell cycle regulated and affects cytokinesis. J. Cell Biol. 163:2003;571-582
48. Plas D.R., Thompson C.B. Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J. Biol. Chem. 278:2003;12361-12366
49. Tsygankova O.M., et al. Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3β elicit opposing effects on Rap1GAP stability. J. Biol. Chem. 279:2004;5501-5507
50. Gao Q., et al. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19:1999;733-744
51. Gao Q., et al. Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J. Virol. 75:2001;4459-4466
52. Dan H.C., et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 277:2002;35364-35370
53. Cichowski K., Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 104:2001;593-604
54. Eerola I., et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am. J. Hum. Genet. 73:2003;1240-1249
55. Henkemeyer M., et al. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature. 377:1995;695-701
56. Faucherre A., et al. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. Hum. Mol. Genet. 12:2003;2449-2456
57. Billuart P., et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature. 392:1998;923-926
58. Kutsche K., et al. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat. Genet. 26:2000;247-250
59. Allen K.M., et al. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 20:1998;25-30
60. Borkhardt A., et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9168-9173
61. Wong C.M., et al. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 63:2003;7646-7651
62. Schaefer L., et al. Cloning and characterization of a novel rho-type GTPase-activating protein gene (ARHGAP6) from the critical region for microphthalmia with linear skin defects. Genomics. 46:1997;268-277